vs
Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $403.4M, roughly 1.9× Madison Square Garden Sports Corp.). Insulet Corporation runs the higher net margin — 13.0% vs 2.0%, a 10.9% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 12.8%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $31.6M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs -3.1%).
Madison Square Garden Sports Corp. is an American sports holding company based in New York City.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
MSGS vs PODD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $403.4M | $783.7M |
| Net Profit | $8.2M | $101.6M |
| Gross Margin | — | 72.6% |
| Operating Margin | 5.5% | 18.7% |
| Net Margin | 2.0% | 13.0% |
| Revenue YoY | 12.8% | 31.2% |
| Net Profit YoY | 641.9% | 0.9% |
| EPS (diluted) | $0.34 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $403.4M | $783.7M | ||
| Q3 25 | $39.5M | $706.3M | ||
| Q2 25 | $204.0M | $649.1M | ||
| Q1 25 | $424.2M | $569.0M | ||
| Q4 24 | $357.8M | $597.5M | ||
| Q3 24 | $53.3M | $543.9M | ||
| Q2 24 | $227.3M | $488.5M | ||
| Q1 24 | $430.0M | $441.7M |
| Q4 25 | $8.2M | $101.6M | ||
| Q3 25 | $-8.8M | $87.6M | ||
| Q2 25 | $-1.8M | $22.5M | ||
| Q1 25 | $-14.2M | $35.4M | ||
| Q4 24 | $1.1M | $100.7M | ||
| Q3 24 | $-7.5M | $77.5M | ||
| Q2 24 | $25.5M | $188.6M | ||
| Q1 24 | $37.9M | $51.5M |
| Q4 25 | — | 72.6% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 69.7% | ||
| Q1 25 | — | 71.9% | ||
| Q4 24 | — | 72.1% | ||
| Q3 24 | — | 69.3% | ||
| Q2 24 | — | 67.7% | ||
| Q1 24 | — | 69.5% |
| Q4 25 | 5.5% | 18.7% | ||
| Q3 25 | -69.5% | 16.7% | ||
| Q2 25 | -11.1% | 18.7% | ||
| Q1 25 | 7.6% | 15.6% | ||
| Q4 24 | 3.7% | 18.3% | ||
| Q3 24 | -15.5% | 16.2% | ||
| Q2 24 | 23.0% | 11.2% | ||
| Q1 24 | 18.5% | 12.9% |
| Q4 25 | 2.0% | 13.0% | ||
| Q3 25 | -22.3% | 12.4% | ||
| Q2 25 | -0.9% | 3.5% | ||
| Q1 25 | -3.4% | 6.2% | ||
| Q4 24 | 0.3% | 16.9% | ||
| Q3 24 | -14.1% | 14.2% | ||
| Q2 24 | 11.2% | 38.6% | ||
| Q1 24 | 8.8% | 11.7% |
| Q4 25 | $0.34 | $1.42 | ||
| Q3 25 | $-0.37 | $1.24 | ||
| Q2 25 | $-0.08 | $0.32 | ||
| Q1 25 | $-0.59 | $0.50 | ||
| Q4 24 | $0.05 | $1.38 | ||
| Q3 24 | $-0.31 | $1.08 | ||
| Q2 24 | $1.07 | $2.59 | ||
| Q1 24 | $1.57 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.3M | — |
| Total DebtLower is stronger | — | $930.8M |
| Stockholders' EquityBook value | $-282.1M | $1.5B |
| Total Assets | $1.5B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.3M | — | ||
| Q3 25 | $48.6M | — | ||
| Q2 25 | $144.6M | — | ||
| Q1 25 | $96.5M | — | ||
| Q4 24 | $107.8M | — | ||
| Q3 24 | $52.3M | — | ||
| Q2 24 | $89.1M | — | ||
| Q1 24 | $40.0M | — |
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $-282.1M | $1.5B | ||
| Q3 25 | $-294.2M | $1.4B | ||
| Q2 25 | $-281.4M | $1.5B | ||
| Q1 25 | $-283.4M | $1.3B | ||
| Q4 24 | $-273.1M | $1.2B | ||
| Q3 24 | $-277.5M | $1.1B | ||
| Q2 24 | $-266.3M | $998.4M | ||
| Q1 24 | $-294.0M | $790.7M |
| Q4 25 | $1.5B | $3.2B | ||
| Q3 25 | $1.5B | $3.0B | ||
| Q2 25 | $1.5B | $3.5B | ||
| Q1 25 | $1.5B | $3.5B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.4B | $3.0B | ||
| Q2 24 | $1.3B | $2.9B | ||
| Q1 24 | $1.4B | $2.6B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $32.4M | $183.3M |
| Free Cash FlowOCF − Capex | $31.6M | $48.2M |
| FCF MarginFCF / Revenue | 7.8% | 6.2% |
| Capex IntensityCapex / Revenue | 0.2% | 17.2% |
| Cash ConversionOCF / Net Profit | 3.94× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $-480.0K | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $32.4M | $183.3M | ||
| Q3 25 | $-85.0M | $125.7M | ||
| Q2 25 | $49.7M | $196.5M | ||
| Q1 25 | $6.3M | $63.8M | ||
| Q4 24 | $61.8M | $147.7M | ||
| Q3 24 | $-26.2M | $98.5M | ||
| Q2 24 | $108.4M | $96.5M | ||
| Q1 24 | $4.0M | $87.6M |
| Q4 25 | $31.6M | $48.2M | ||
| Q3 25 | $-85.3M | $100.1M | ||
| Q2 25 | $49.4M | $177.9M | ||
| Q1 25 | $3.9M | $51.5M | ||
| Q4 24 | $61.2M | $94.1M | ||
| Q3 24 | $-26.5M | $71.8M | ||
| Q2 24 | $108.0M | $74.0M | ||
| Q1 24 | $3.9M | $65.5M |
| Q4 25 | 7.8% | 6.2% | ||
| Q3 25 | -216.3% | 14.2% | ||
| Q2 25 | 24.2% | 27.4% | ||
| Q1 25 | 0.9% | 9.1% | ||
| Q4 24 | 17.1% | 15.7% | ||
| Q3 24 | -49.7% | 13.2% | ||
| Q2 24 | 47.5% | 15.1% | ||
| Q1 24 | 0.9% | 14.8% |
| Q4 25 | 0.2% | 17.2% | ||
| Q3 25 | 0.9% | 3.6% | ||
| Q2 25 | 0.2% | 2.9% | ||
| Q1 25 | 0.6% | 2.2% | ||
| Q4 24 | 0.1% | 9.0% | ||
| Q3 24 | 0.7% | 4.9% | ||
| Q2 24 | 0.2% | 4.6% | ||
| Q1 24 | 0.0% | 5.0% |
| Q4 25 | 3.94× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | — | 1.80× | ||
| Q4 24 | 55.61× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | 4.25× | 0.51× | ||
| Q1 24 | 0.11× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSGS
| Event Related | $167.2M | 41% |
| Media Rights | $122.3M | 30% |
| Sponsorship Signage And Suite Licenses | $98.5M | 24% |
| League Distribution | $15.4M | 4% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
